TRIM25 and neoplasm: Conversely, the authors of the study observed that treatment of tumor cells with the antibacterial compound nitroxoline by counteracting TRIM25-mediated PTEN ubiquitination was able to restore cell death sensitivity of NSCLC to cisplatin [75].